Latest period
73.74M
YoY change
+4.0%
5Y CAGR
+4.8%
Peak year (2025)
73.74M
Latest annual
73.74M
Shares Outstanding history chart for Ovid Therapeutics (OVID) from 2014 to 2025
Latest: 73.74M
Shares Outstanding growth chart for Ovid Therapeutics (OVID) from 2014 to 2025
Latest: +4.0%
Shares Outstanding history table for Ovid Therapeutics (OVID) from 2014 to 2025
| 2025 | 73.74M | +4.0% | +2.83M | ||
| 2024 | 70.91M | +0.5% | +324,000 | ||
| 2023 | 70.58M | +0.2% | +156,000 | ||
| 2022 | 70.42M | +3.5% | +2.36M | ||
| 2021 | 68.07M | +16.5% | +9.62M | ||
| 2020 | 58.45M | +49.0% | +19.23M | ||
| 2019 | 39.22M | +59.2% | +14.59M | ||
| 2018 | 24.63M | +27.3% | +5.29M | ||
| 2017 | 19.34M | -1.3% | -258,000 | ||
| 2016 | 19.60M | 0.0% | 0 | ||
| 2015 | 19.60M | +312.4% | +14.85M | ||
| 2014 | 4.75M | — | — |
- 202573.74M+4.0%
- 202470.91M+0.5%
- 202370.58M+0.2%
- 202270.42M+3.5%
- 202168.07M+16.5%
- 202058.45M+49.0%
- 201939.22M+59.2%
- 201824.63M+27.3%
- 201719.34M-1.3%
- 201619.60M0.0%
- 201519.60M+312.4%
- 20144.75M—
Shares Outstanding values are taken from Ovid Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Ovid Therapeutics (OVID)
According to Ovid Therapeutics's latest reported financial statements, the company's latest reported diluted shares outstanding is 73.74M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Ovid Therapeutics (OVID) reported diluted shares outstanding of 73.74M – edged up 4.0% year-over-year.
Across 2020–2025 (5 years), Ovid Therapeutics diluted shares outstanding produced a CAGR of +4.8% – sustaining 8 straight years of year-over-year growth.
73.74M stands as the all-time-high annual diluted shares outstanding, posted in 2025, against a low of 4.75M during 2014.
Ovid Therapeutics Shares Outstanding by Year
Ovid Therapeutics Shares Outstanding 2025: 73.74M
In 2025, Ovid Therapeutics reported diluted shares outstanding of 73.74M, edged up 4.0% from 2024. This figure represents the highest annual value in the available history.
Ovid Therapeutics Shares Outstanding 2024: 70.91M
Ovid Therapeutics diluted shares outstanding in 2024 was 70.91M, edged up 0.5% from 2023.
Ovid Therapeutics Shares Outstanding 2023: 70.58M
2023's diluted shares outstanding for Ovid Therapeutics came in at 70.58M, edged up 0.2% from 2022.
Ovid Therapeutics Shares Outstanding 2022: 70.42M
Ovid Therapeutics posted diluted shares outstanding of 70.42M in 2022, edged up 3.5% from 2021.
Ovid Therapeutics Shares Outstanding 2021: 68.07M
Ovid Therapeutics diluted shares outstanding in 2021 was 68.07M.
See more financial history for Ovid Therapeutics (OVID).
Sector peers by Shares Outstanding
Healthcare peers of Ovid Therapeutics (OVID), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation